Efficacy evaluation of targeted therapy in patient with gastrointestinal stromal tumor
- Authors: Meshcheryakov A.A.1, Tsymzhitova N.T.1, Filonenko D.A.1, Medvedeva B.M.1
-
Affiliations:
- FGBU N.N. Blokhin Russian Cancer Research Center
- Issue: Vol 5, No 2 (2013)
- Pages: 38-42
- Section: SOFT TISSUE SARCOMAS
- Published: 03.05.2013
- URL: https://sarbon.abvpress.ru/jour/article/view/512
- ID: 512
Cite item
Full Text
Abstract
An evaluation of efficacy of Gleevec in gastrointestinal stromal tumor is under discussion. Standard RECIST criteria underestimate the tumor response in contrast with highly sensitive PET evaluation. Proposed criteria modifications offer CT response evaluation. We demonstrated a difference between response criteria presenting a clinical case.
About the authors
A. A. Meshcheryakov
FGBU N.N. Blokhin Russian Cancer Research Center
Author for correspondence.
Email: a_meshcheryakov@mail.ru
Russian Federation
N. T. Tsymzhitova
FGBU N.N. Blokhin Russian Cancer Research CenterRussian Federation
D. A. Filonenko
FGBU N.N. Blokhin Russian Cancer Research CenterRussian Federation
B. M. Medvedeva
FGBU N.N. Blokhin Russian Cancer Research CenterRussian Federation
References
Supplementary files


